Big Pharma Giant Bests Wall Street Expectations After Hiking Prices In January


Yet another brand name drug company announced last week it had surpassed earnings expectations after hiking prices on American patients. On Friday, Big Pharma giant AbbVie reported sky-high profits after enacting a series of price hikes throughout 2019.

AbbVie continues to hike prices on American patients, despite the escalating crisis of affordability and heightened attention around out-of-control prescription drug prices.

And, AbbVie is among the most notorious Big Pharma companies that game the system to undermine competition and keep prices high.

Here are just a few examples:

AbbVie joins a slew of Big Pharma giants who have reported expectation-besting earnings for the fourth quarter of 2019 after hiking prices on American patients – Johnson & Johnson, Eli Lilly, Roche, Novartis, Pfizer, Amgen, Merck, GlaxoSmithKline & Bristol-Myers Squibb. Stay tuned for more as fourth quarter earnings reports continue to roll in.



Sign-up for updates

  • This field is for validation purposes and should be left unchanged.